Creative Medical Technology (CELZ) Competitors $3.51 0.00 (0.00%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$3.51 0.00 (0.00%) As of 09/19/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. MURA, MRSN, SNTI, RANI, DYAI, XFOR, JATT, RENB, OKUR, and ITRMShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Mural Oncology (MURA), Mersana Therapeutics (MRSN), Senti Biosciences (SNTI), Rani Therapeutics (RANI), Dyadic International (DYAI), X4 Pharmaceuticals (XFOR), JATT Acquisition (JATT), Renovaro (RENB), OnKure Therapeutics (OKUR), and Iterum Therapeutics (ITRM). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Its Competitors Mural Oncology Mersana Therapeutics Senti Biosciences Rani Therapeutics Dyadic International X4 Pharmaceuticals JATT Acquisition Renovaro OnKure Therapeutics Iterum Therapeutics Mural Oncology (NASDAQ:MURA) and Creative Medical Technology (NASDAQ:CELZ) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends. Do analysts recommend MURA or CELZ? Mural Oncology presently has a consensus target price of $12.00, indicating a potential upside of 476.92%. Given Mural Oncology's stronger consensus rating and higher possible upside, equities analysts clearly believe Mural Oncology is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mural Oncology 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Creative Medical Technology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility & risk, MURA or CELZ? Mural Oncology has a beta of 2.99, indicating that its share price is 199% more volatile than the S&P 500. Comparatively, Creative Medical Technology has a beta of 2.06, indicating that its share price is 106% more volatile than the S&P 500. Which has preferable earnings and valuation, MURA or CELZ? Creative Medical Technology has higher revenue and earnings than Mural Oncology. Creative Medical Technology is trading at a lower price-to-earnings ratio than Mural Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMural OncologyN/AN/A-$128.51M-$8.59-0.24Creative Medical Technology$10K905.58-$5.49M-$3.18-1.10 Is MURA or CELZ more profitable? Creative Medical Technology's return on equity of -82.99% beat Mural Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Mural OncologyN/A -107.76% -87.57% Creative Medical Technology N/A -82.99%-79.49% Does the media favor MURA or CELZ? In the previous week, Mural Oncology's average media sentiment score of 0.00 equaled Creative Medical Technology'saverage media sentiment score. Company Overall Sentiment Mural Oncology Neutral Creative Medical Technology Neutral Do insiders & institutionals believe in MURA or CELZ? 80.2% of Mural Oncology shares are owned by institutional investors. Comparatively, 1.4% of Creative Medical Technology shares are owned by institutional investors. 2.2% of Mural Oncology shares are owned by insiders. Comparatively, 1.8% of Creative Medical Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryMural Oncology beats Creative Medical Technology on 7 of the 12 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.06M$3.15B$5.79B$10.46BDividend YieldN/A2.36%5.61%4.57%P/E Ratio-1.1021.0580.5726.86Price / Sales905.58445.77536.23125.79Price / CashN/A44.8326.0131.15Price / Book0.979.6215.776.42Net Income-$5.49M-$53.02M$3.30B$271.73M7 Day Performance0.86%1.43%3.93%2.82%1 Month Performance10.03%3.42%5.32%6.60%1 Year Performance12.50%11.20%80.88%28.60% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology0.7816 of 5 stars$3.51flatN/A+12.5%$9.06M$10K-1.105Gap DownMURAMural Oncology2.7273 of 5 stars$2.07flat$12.00+479.7%-38.5%$35.86MN/A-0.24119MRSNMersana Therapeutics4.0974 of 5 stars$7.21+0.6%$56.60+685.0%-86.6%$35.78M$40.50M-0.49150SNTISenti Biosciences2.5522 of 5 stars$1.39+2.2%$8.50+511.5%-57.1%$35.58M$2.56M-0.164News CoverageShort Interest ↓RANIRani Therapeutics2.5063 of 5 stars$0.50+2.3%$7.33+1,369.6%-78.0%$35.06M$1.03M-0.55110DYAIDyadic International2.9022 of 5 stars$0.99+2.6%$6.00+505.6%-14.4%$34.94M$3.49M-5.217News CoverageXFORX4 Pharmaceuticals4.2843 of 5 stars$3.21+7.4%$34.17+964.4%-85.1%$34.11M$2.56M-0.2280JATTJATT AcquisitionN/A$1.92-4.0%N/A-55.2%$33.12MN/A0.003High Trading VolumeRENBRenovaro0.443 of 5 stars$0.18-4.0%N/A-66.3%$32.82MN/A-0.2420Upcoming EarningsGap UpHigh Trading VolumeOKUROnKure Therapeutics2.9893 of 5 stars$2.37-0.8%$32.33+1,264.3%N/A$32.34MN/A-0.49N/ANews CoverageITRMIterum Therapeutics2.5211 of 5 stars$0.68-0.7%$9.00+1,224.9%-36.5%$32.26MN/A-0.8010News CoverageShort Interest ↓Gap Up Related Companies and Tools Related Companies Mural Oncology Alternatives Mersana Therapeutics Alternatives Senti Biosciences Alternatives Rani Therapeutics Alternatives Dyadic International Alternatives X4 Pharmaceuticals Alternatives JATT Acquisition Alternatives Renovaro Alternatives OnKure Therapeutics Alternatives Iterum Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThis Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top...Crypto 101 Media | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CELZ Stock Alerts